Looking to refine its Stage 2 recommendations before presenting them to the full HIT Policy Committee, the Meaningful Use Workgroup this week debated whether eligible providers (EPs) should have to report appropriate lab values, conditions or both to public health agencies. While hospitals are required to do so under Stage 1 of Meaningful Use, “EPs […]